Treace Medical Concepts, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-15.9M | $-18.0M | $-9.4M | $-16.3M | $-17.4M | $-15.9M | $-501.0K | $-15.4M |
| Depreciation & Amortization | $1.9M | $899.0K | $2.8M | $2.8M | $2.6M | $2.5M | $2.2M | $2.2M |
| Depreciation | $1.5M | — | — | — | $2.3M | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $6.5M | $8.0M | $7.6M | $8.0M | $9.6M | $8.7M | $8.6M | $7.9M |
| Net Cash from Operating Activities | $-4.7M | $7.2M | $-8.0M | $-9.1M | $-3.1M | $4.2M | $-4.2M | $-11.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $2.2M | $3.1M | $2.4M | $2.8M | $4.8M | $3.5M | $3.1M | $2.9M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $7.1M | $-7.8M | $9.7M | $8.7M | $-3.3M | $-1.9M | $3.4M | $5.8M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $696.0K | $-588.0K | $1.4M | $-10.0K | $987.0K | $-282.0K | $26.0K | $8.0K |
| Net Change in Cash | $3.1M | $-1.2M | $3.0M | $-366.0K | $-5.3M | $2.0M | $-760.0K | $-6.1M |
| Free Cash Flow | $-6.9M | $4.2M | $-10.4M | $-11.9M | $-7.8M | $655.0K | $-7.3M | $-14.7M |